Also trades as: DRUG.CN (CNQ) · $vol 0M
DRUG NASDAQ
Bright Minds Biosciences Inc.
1W: -11.9%
1M: -17.9%
3M: -7.2%
YTD: -10.7%
1Y: +125.9%
3Y: +2470.3%
5Y: +218.0%
$82.78
+8.24 (+11.05%)
After Hours: $80.25 (-2.53, -3.06%)
Weekly Expected Move ±6.3%
$68
$73
$77
$82
$87
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Smart Money Score
Watch
25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$578.5M
52W Range23.175-123.75
Volume234,754
Avg Volume166,022
Beta-0.19
Dividend—
Analyst Ratings
Company Info
CEOIan McDonald
Employees26
SectorHealthcare
IndustryBiotechnology
IPO Date2021-03-22
Websitebrightmindsbio.com
1500 â 1055 West Georgia Street
New York City, BC V6E 4N7
CA
New York City, BC V6E 4N7
CA
647 407 2515
About Bright Minds Biosciences Inc.
Bright Minds Biosciences Inc., a pre-clinical biosciences company, develops 5-HT (serotonin) medicines to improve the lives of patients with severe and life-altering diseases. Its portfolio of selective 5-HT receptor agonists comprises 5-HT2C, 5-HT2A, and 5-HT2C/A for the treatment of epilepsy, pain, and neuropsychiatry. The company has collaboration with National Institutes of Health for the treatment of epilepsy; University of Texas Medical Branch to treat impulse control disorders, such as binge eating; and Medical College of Wisconsin. The company was incorporated in 2019 and is headquartered in Vancouver, Canada.
Latest News
Shroom stocks rise as Trump is said to sign executive order on psychedelic drug
Bright Minds Biosciences to Present at Upcoming Conferences
Bright Minds Biosciences Inc. (NASDAQ:DRUG) Receives Consensus Recommendation of “Moderate Buy” from Analysts
Bright Minds Biosciences Announces Closing of US$175 Million Public Offering
Bright Minds Biosciences Announces Pricing of Upsized US$175 Million Public Offering of Common Stock
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Cormorant Asset Mana | S-Sale | 109,331 | $89.50 | 2026-04-28 |
| Cormorant Asset Mana | P-Purchase | 184,331 | $21.70 | 2024-11-04 |
| Cormorant Asset Mana | P-Purchase | 3,107 | $25.22 | 2024-10-16 |
| Cormorant Asset Mana | P-Purchase | 7,150 | $24.03 | 2024-10-16 |
| Cormorant Asset Mana | P-Purchase | 39,743 | $23.21 | 2024-10-16 |